Analyst Price Targets — ACA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 4, 2026 9:11 am | Adam Seiden | Barclays | $140.00 | $124.76 | TheFly | Arcosa price target raised to $140 from $115 at Barclays |
| November 3, 2025 11:32 am | Adam Seiden | Barclays | $115.00 | $102.00 | TheFly | Arcosa price target raised to $115 from $106 at Barclays |
| October 29, 2024 5:49 am | Adam Seiden | Barclays | $106.00 | $95.42 | TheFly | Arcosa initiated with an Overweight at Barclays |
| August 7, 2024 6:16 am | Trey Grooms | Stephens | $96.00 | $77.70 | TheFly | Arcosa upgraded to Overweight at Stephens on benefits of portfolio actions |
| August 5, 2024 9:12 am | Garik Shmois | Loop Capital Markets | $110.00 | $79.12 | TheFly | Arcosa price target raised to $110 from $95 at Loop Capital |
| May 17, 2024 8:29 am | Brent Thielman | D.A. Davidson | $110.00 | $86.82 | TheFly | Arcosa price target raised to $110 from $105 at DA Davidson |
| May 6, 2024 9:13 am | Brent Thielman | D.A. Davidson | $105.00 | $86.34 | StreetInsider | Arcosa (ACA) PT Raised to $105 at DA Davidson |
| August 8, 2022 9:20 am | — | Stephens | $70.00 | $62.79 | Benzinga | Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70 |
Latest News for ACA
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation.
BALA CYNWYD, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Arcosa (NYSE: ACA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with CRH.
BALA CYNWYD, Pa., June 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for ACA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.